We’re pleased to re-publish this important article by Sara Flounders, posted in Workers World on 7 June 2022, about the progress made by a Cuban-Chinese cooperation project towards a universal coronavirus vaccine. Sara explains that these two socialist countries are far better positioned than their capitalist counterparts to work together on projects of long-term value to humanity, because their social systems are centered on meeting human need, as opposed to maximizing private profit. The article goes on to detail the outsized contribution made by China and Cuba to suppressing the pandemic in the developing world, as well as the ongoing and deepening cooperation between the two countries in a number of crucially important areas. Sara concludes: “The growing scientific cooperation of China and Cuba represents a hopeful future for humanity. Global problems can be solved. What is required is economic planning, cooperation and sharing of scientific knowledge and technology.”
Cuba and China formally announced June 2 that they have filed for joint patent for a Pan-Corona vaccine. The new vaccine, a collaboration between the biotechnological sectors of the two countries, is the first patent for a single vaccine effective against the many variants of COVID-19.
News of the jointly developed vaccine is particularly exciting because of the two countries’ cooperative approach in a field that is highly competitive, secretive and totally profit-oriented in Western capitalist countries.
Breakthrough in emerging virus protection
The Pan-Corona vaccine was announced to be effective against present variants of COVID-19 and thus of value in the current pandemic.
But its strength is that it could also be effective against the appearance of new pathogens belonging to this family of viruses, noted Eduardo Martínez Díaz, president of the state-owned BioCubaFarma Business Group. (telesurenglish.net, June 3)
The Pan-Corona project is based in a joint biotechnological research and development center, operating since 2019 in the city of Yongzhou in Hunan province, and led by experts from Cuba’s Center for Genetic Engineering and Biotechnology (CIGB). Dr. Gerardo Guillén Nieto, the center’s director of Biomedical Research, explained the project arose at the request of the Chinese and had the approval of Cuba’s Ministry of Science, Technology and Environment. The equipment and laboratories at the Yongzhou center were designed by Cuban scientific personnel. (Radio Havana Cuba, June 3)
The two countries focused on coronaviruses because of the global pandemic and because this is the family of viruses most likely to jump from animals to humans. This phenomenon, called zoonosis, was the cause of previous epidemics such as the 2002 SARS outbreak and the 2012 MERS infection — both serious respiratory illnesses.Continue reading Cuba-China cooperation leads to vaccine breakthrough